Overall Earnings Trend and Market Cap Analysis

The latest quarterly results indicate a clear upward trajectory in the proportion of companies reporting positive earnings. From a low of 41.0% in June 2025, the share of positive results has climbed consistently to 54.0% in March 2026. This improvement underscores a gradual but sustained recovery in corporate earnings momentum across sectors.

Breaking down by market capitalisation, mid cap companies led the charge with 59.0% reporting positive results, followed by small caps at 54.0%, and large caps trailing at 47.0%. The mid cap segment’s outperformance suggests that mid-sized firms are benefiting from favourable demand conditions and operational efficiencies, while large caps continue to face headwinds from global macroeconomic uncertainties and sector-specific challenges.

Sectoral Highlights and Top Performers

Among large caps, Muthoot Finance stood out with robust results in the Non-Banking Financial Company (NBFC) sector, reflecting strong credit demand and improved asset quality. The company’s performance was a key contributor to the large cap segment’s overall positive results, despite the segment’s relatively lower positivity rate.

In the mid cap space, Multi Commodity Exchange (Multi Comm. Exc.) delivered impressive earnings, benefiting from increased trading volumes and volatility in commodity markets. This performance highlights the resilience of capital markets firms amid fluctuating economic conditions.

Small caps showcased some of the most remarkable results, with Puravankara in the Realty sector leading the pack. The company’s strong sales and margin expansion were indicative of a revival in real estate demand. Other notable small cap performers included Navin Fluorine International from Specialty Chemicals and Navkar Corporation in Transport Services, both reporting significant profit growth and operational improvements.

Detailed Financial Performance: Ind-Swift Laboratories Ltd

Among the 238 companies that declared results in the last 24 hours, Ind-Swift Laboratories Ltd, a Pharmaceuticals & Biotechnology firm with a market size of ₹1,198 crores, posted a very positive quarterly performance. The company’s financial metrics for March 2026 reveal strong growth across key parameters:

• PBT (Profit Before Tax) excluding other income rose by 47.13% to ₹14.89 crores.
• Profit After Tax (PAT) surged 44.1% to ₹20.26 crores, marking the highest quarterly PAT recorded.
• Net sales reached a record ₹169.79 crores, up 22.82% year-on-year.
• PBDIT (Profit Before Depreciation, Interest and Tax) also hit a peak at ₹20.58 crores.
• Operating profit margin improved to 12.12%, the highest in recent quarters.

These results have contributed to an upgrade in the company’s outlook from Bullish to Mildly Bullish as of 23 April 2026, with the overall score improving from 26 to 27 over the past three months. Ind-Swift’s performance exemplifies the strength of select pharmaceutical firms capitalising on robust demand and operational efficiencies.

Sectoral Patterns and Earnings Quality

The earnings season has highlighted divergent sectoral trends. While financial services and capital markets firms have generally reported improved profitability, sectors such as realty and specialty chemicals have shown signs of revival after a period of subdued performance. The small cap segment’s strong showing is particularly noteworthy, as it often serves as a barometer for domestic economic activity and investor sentiment.

However, the large cap segment’s relatively modest positive result ratio suggests ongoing challenges, including inflationary pressures, input cost volatility, and geopolitical uncertainties impacting multinational operations. Investors should remain cautious and selective, favouring companies with strong balance sheets and sustainable earnings growth.

Upcoming Earnings to Watch

Market participants will closely monitor the results of several key companies scheduled to report shortly, including Patanjali Foods Ltd, Linde India Ltd., and Steelcast Ltd on 30 May 2026. These results will provide further clarity on sectoral momentum and the sustainability of the current earnings recovery.

Conclusion: Earnings Recovery Gains Traction but Selectivity Remains Key

The March 2026 quarter earnings season reflects a broad-based improvement in corporate profitability across market capitalisation segments, with mid and small caps leading the recovery. The steady rise in positive results from 41.0% in June 2025 to 54.0% in March 2026 signals strengthening business fundamentals and improving investor confidence.

Nonetheless, the mixed performance across sectors and the relatively lower positivity ratio among large caps underscore the need for investors to adopt a discerning approach. Companies demonstrating consistent margin expansion, robust sales growth, and operational resilience are likely to outperform in the near term.

As the earnings season progresses, monitoring upcoming results and sectoral developments will be crucial for identifying sustainable investment opportunities in an evolving market landscape.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →